DEVELOPMENT AND VALIDATION OF AN ALTERNATIVE ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE WHEN PATIENT GLOBAL ASSESSMENT IS UNAVAILABLE

被引：0

作者：

Ortolan, A. ^{[1
,2
]}

Ramiro, S. ^{[1
,3
]}

Van Gaalen, F. A. ^{[1
]}

Kvien, T. K. ^{[4
]}

Landewe, R. B. M. ^{[3
,5
]}

Machado, P. M. ^{[6
,7
]}

Ruyssen-Witrand, A. ^{[8
]}

Van Tubergen, A. ^{[9
]}

Bastiaenen, C. ^{[10
]}

Van der Heijde, D. ^{[1
]}

机构：

[1] LUMC, Leiden, Netherlands

[2] Univ Padua, Padua, Italy

[3] Zuyderland MC, Herleen, Netherlands

[4] Diakonhjemmet Hosp, Oslo, Norway

[5] AUMC, Amsterdam, Netherlands

[6] UCL, London, England

[7] UCL Hosp NHS Fdn Trust, London, England

[8] Purpan Teaching Hosp, Toulouse, France

[9] MUMC, Maastricht, Netherlands

[10] Maastricht Univ, Maastricht, Netherlands

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷

关键词：

D O I：

10.1136/annrheumdis-2020-eular.1122

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OP0008

引用

页码：6 / 6

页数：1

共 50 条

[1] Comment on: Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable
Aranda-Valera, Inmaculada C.
Garrido-Castro, Juan L.
Ladehesa, Lourdes
Vazquez-Mellado, Janitzia
Zarco, Pedro
Juanola, Xavier
Gonzalez-Navas, Cristina
Font-Ugalde, Pilar
Castro-Villegas, M. Carmen
RHEUMATOLOGY, 2021, 60 (02) : E69 - E70
[2] Comment on: Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable: reply
Ortolan, Augusta
Ramiro, Sofia
Bastiaenen, Caroline
van der Heijde, Desiree
RHEUMATOLOGY, 2021, 60 (02) : E71 - E72
[3] Development of a disease activity score for patients with ankylosing spondylitis
Landewe, R.
Lukas, C.
Braun, J.
Davis, J.
Dougados, M.
Van der Linden, S.
Sieper, J.
Van der Heijde, D.
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 532 - 533
[4] External validation of the alternative Ankylosing Spondylitis Disease Activity Score in three randomized clinical trials of ixekizumab
Ortolan, Augusta
Ramiro, Sofia
Ramonda, Roberta
van der Heijde, Desiree
RHEUMATOLOGY, 2023, 62 (06) : 2257 - 2261
[5] EXTERNAL VALIDATION OF THE ALTERNATIVE ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE IN THREE PHASE-3 RCTS
Ortolan, A.
Ramiro, S.
Van der Heijde, D.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 784 - 784
[6] EXTERNAL VALIDATION OF THE ALTERNATIVE ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE IN THREE PHASE-3 RCT
Ortolan, A.
Ramiro, S.
van der Heijde, D.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1194 - 1194
[7] Comparison of Ankylosing Spondylitis Disease Activity Score and Bath Ankylosing Spondylitis Disease Activity Index tools in assessment of axial spondyloarthritis activity
Wiak-Walerowicz, Katarzyna
Wielosz, Ewa
REUMATOLOGIA, 2024, 62 (01): : 64 - 69
[8] VALIDATION OF THE ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE (ASDAS) AND EFFECTIVENESS OF INFLIXIMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS OVER 4 YEARS
Rahman, P.
Choquette, D.
Khraishi, M.
Bensen, W.
Shaikh, S.
Sholter, D.
Sheriff, M.
Rampakakis, E.
Sampalis, J. S.
Nantel, F.
Otawa, S.
Lehman, A.
Shawi, M.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 725 - 725
[9] VALIDATION OF THE ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE (ASDAS) AND EFFECTIVENESS OF INFLIXIMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS OVER 4 YEARS
Rahman, P.
Choquette, D.
Khraishi, M.
Bensen, W. G.
Shaikh, S. A.
Sholter, D.
Sheriff, M.
Rampakakis, E.
Sampalis, J. S.
Nantel, F.
Otawa, S.
Lehman, A. J.
Shawi, M.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : 828 - 829
[10] Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing Spondylitis Global Score (BASG)
El Miedany, Yasser
Youssef, Sally
Mehanna, Annie
Shebrya, Naglaa
Abu Gamra, Sherif
El Gaafary, Maha
CLINICAL RHEUMATOLOGY, 2008, 27 (05) : 605 - 612

← 1 2 3 4 5 →